Henry Meds and Tirzepatide: Compounded Model and Pricing

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

From the PlexusDx Education Hub: clear, research-grounded explainers on GLP-1 medications, weight-management protocols, and the genetics behind every metabolic response. Browse all Peptides & GLP-1 education

This is independent editorial coverage. PlexusDx maintains no commercial relationship with Henry Meds or its parent company, and no affiliate links or compensation appear on this page.

Henry Meds is one of several telehealth brands prescribing GLP-1 medications. This review zeroes in on tirzepatide: how the compound works, how Henry offers it, and how compounded tirzepatide differs from the branded product. It is fair-balance editorial context, not a purchase recommendation, current as of April 2026.

What makes tirzepatide different from single-target GLP-1 drugs

Tirzepatide is a dual agonist: it activates both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor, whereas semaglutide and liraglutide act on the GLP-1 receptor alone. That dual mechanism is why tirzepatide is studied as its own category within metabolic pharmacology rather than lumped in with single-pathway agonists.

How Henry Meds handles tirzepatide

Oral dissolving tablets only

As of July 2026, Henry offers tirzepatide exclusively as oral dissolving tablets; it does not provide an injectable tirzepatide. The tablets are sold as a three-month supply priced at $1,047, or $891 paid in full, and Henry publishes no month-to-month tirzepatide rate. Verified July 20, 2026.

Compounded versus branded

Henry's tirzepatide is compounded through a 503A pharmacy rather than dispensed as an FDA-approved brand. Compounded preparations are made to a prescription and are not FDA-approved products; branded tirzepatide, by contrast, is a manufacturer product routed through a retail pharmacy. The distinction affects sourcing, formulation, and oversight, and is worth confirming directly with the provider.

What the trials show for tirzepatide

Tirzepatide's evidence base centers on the SURMOUNT program for weight management, published in The New England Journal of Medicine in 2022, and SURMOUNT-OSA for obstructive sleep apnea, published in NEJM in 2024. Trial populations and endpoints differ from study to study, and individual outcomes vary. This is research context, not a promise of any particular result.

The rest of Henry's medication ladder

For context alongside tirzepatide, Henry's other options as verified July 20, 2026 include injectable compounded semaglutide at $297 per month month-to-month (lower on prepaid six- and twelve-month plans), sublingual semaglutide at $249 with a $179 tier, injectable liraglutide at $179, and oral phentermine at $149. Henry charges no membership or consultation fee, and the provider evaluation is free until a prescription is written.

The genetic context behind any tirzepatide response

Tirzepatide acts on receptors, but the receptors and the metabolic machinery around them are shaped by your genes. Variants in GLP1R (the GLP-1 receptor tirzepatide partly targets), FTO, MC4R, and TCF7L2 influence satiety, energy balance, and glucose regulation at the pathway level. They do not predict how you will respond to tirzepatide specifically, but they describe the biology the compound is entering.

This is where PlexusDx differs. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, with GLP1R, FTO, MC4R, and TCF7L2 among them, so a tirzepatide decision starts with your baseline metabolic profile rather than guesswork.

PlexusDx tirzepatide and semaglutide options

PlexusDx offers both compounds through its Weight Management Protocols, including Tirzepatide Injection, Tirzepatide Oral, Semaglutide Injection, and Semaglutide Oral, paired with upstream genetic context most telehealth programs leave out.

Not affiliated: PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies referenced in this article.

Related reading on PlexusDx: Mounjaro Subscription, Mounjaro vs Liraglutide, Hers Mounjaro, Hims Mounjaro.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols, semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions About Henry Meds and Tirzepatide

Does Henry Meds offer injectable tirzepatide?

No. As of July 2026, Henry offers tirzepatide only as oral dissolving tablets, not as an injectable. The tablets are sold as a three-month supply at $1,047, or $891 paid in full, with no published month-to-month tirzepatide rate. Verify the current format on Henry's official website.

Is Henry's tirzepatide the same as the branded drug?

Not exactly. Henry's tirzepatide is compounded through a 503A pharmacy and is not an FDA-approved brand product. Branded tirzepatide is a manufacturer product dispensed through retail pharmacies. The two differ in formulation, sourcing, and regulatory status, so confirm which you are receiving with the prescribing provider.

How does tirzepatide differ from semaglutide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist, while semaglutide targets the GLP-1 receptor alone. The mechanisms differ, and their trial programs, SURMOUNT for tirzepatide and STEP for semaglutide, studied different populations and endpoints. Individual outcomes vary between people and between compounds.

Can the genetic test tell me if tirzepatide will work for me?

No. The Precision Peptide Genetic Test never predicts response to tirzepatide or any specific medication. It analyzes pathway-level variants such as GLP1R, FTO, MC4R, and TCF7L2 that describe your baseline metabolic biology, useful context for a provider conversation rather than a forecast of drug results.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.